Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
about
Mesenchymal-to-endothelial transition in Kaposi sarcoma: a histogenetic hypothesis based on a case series and literature reviewHuman herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cellsHuman herpesvirus 8--a novel human pathogenIdentification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirusIdentification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirusAwareness of Kaposi's sarcoma-associated herpesvirus among men who have sex with menAsynchronous progression through the lytic cascade and variations in intracellular viral loads revealed by high-throughput single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection.The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigenHuman herpesvirus 6The viral etiology of AIDS-associated malignanciesThe conundrum of causality in tumor virology: the cases of KSHV and MCVInhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomersKSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcomaMolecular virology of Kaposi's sarcoma-associated herpesvirusAntiviral drug susceptibility of human herpesvirus 8Oncogenic herpesvirus KSHV Hijacks BMP-Smad1-Id signaling to promote tumorigenesisSeroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, ChinaComplex alternative cytoplasmic protein isoforms of the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 generated through noncanonical translation initiation.Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma.Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNAIdentification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoproteinCharacterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter.Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cellsHigh-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populationsGuidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerKinetics of Kaposi's sarcoma-associated herpesvirus gene expression.Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein.High human herpesvirus 8 seroprevalence in the homosexual population in SwitzerlandPerspective on Kaposi's sarcoma: facts, concepts, and conjectures.Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirusHuman retroviruses: their role in cancer.Human herpesvirus 8: is it a tumor virus?Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcomaCharacterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesisLong-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8.Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene.
P2860
Q21132551-B497411E-037B-486B-82FB-03EB0D5723F5Q24527215-297318C8-3F54-4429-9C63-F807B4E8DE96Q24530670-70FB9A55-6FF3-40DF-A603-DCBAB8AADC91Q24561400-D9D4CCC5-8600-4573-8EF3-9858816DF4F3Q24646461-331331DF-2168-4552-86C4-894F66423352Q24651220-3D6B2487-F44D-4301-8E57-39C552AA6BD6Q24670607-F4696273-DD67-4EC1-8D89-CB569BA513BDQ24672438-07878AC8-FF48-4883-8278-060E59D9AA4FQ24683663-D7B2F3B2-50CE-49D5-A843-6AB5B0BED6D5Q24685892-FFA1E5F0-DECF-432D-BD22-88EDFFBCAE98Q26863112-3C743D0B-339D-445A-A35B-2532B8ADDC32Q27486093-F39CD276-AB7D-414F-9CA5-3C93C22BE44AQ28284765-EADD9F4C-383B-41B7-964A-C1D290D30DAFQ28363323-0D6778F9-B5F3-4CC0-89C9-671D2EC169C8Q28379288-A8A6C30C-C2A4-4FDB-8839-ACA73C61B17AQ28540651-FC827834-4E6A-4120-8FAC-9E64DCA22C60Q28750969-85F83738-755E-402D-8F18-59D837174B94Q30535717-E4E3A075-FCA7-47FD-B91D-09C59C6E64C5Q33178955-CFCC7C6C-5A2E-45FB-9CA4-B8F84A036F7DQ33432690-C905673B-CC50-4429-99CC-5AD0CFF63302Q33560572-9314080D-11F3-4083-9724-33C935E60755Q33625562-48A4DAEF-6416-45EB-9D28-5014E2405AE3Q33641311-13E89E0D-CFFB-4274-AF5A-A2F623F2EA33Q33641552-F6BBE3A4-E869-4D42-B429-0F50CCB1EAF1Q33647345-C6C681DA-9030-474C-8B7F-5C9387F49BC4Q33647633-4CFD54D0-77A4-49F9-94A6-6A69C5DDBDF7Q33650105-3501DDDB-613B-49DB-96C7-B187E9AA5150Q33653424-961DDE2C-47DE-45FE-9003-E0CA5ED4DFFFQ33669136-6F7EA02F-7FA8-42BE-8EAC-C63AA7E8F14AQ33671148-1AE67D58-368B-40A9-8CE4-351A33A90F50Q33724002-201F8CA5-8EF9-4897-B209-11813C63901AQ33772234-43E866E5-7CC6-4D95-9F99-6DAF288DDE79Q33784966-1435F4A4-EA43-42C4-BBDF-93C392D718F7Q33790602-3222C2DD-B160-464F-95CF-A0B9B46E76F3Q33790621-07192774-15BF-40F0-BEB6-1F77FA963D4FQ33801927-28E2546A-4BA8-4E56-8CB4-02C1F113AB7AQ33814510-525BCE58-37CD-464F-B04F-3935F300D60FQ33815875-BF0F3B25-494E-4FAB-96D3-2D7E52A221A7Q33817882-7BB9987D-F9C8-43BD-AD71-73648503C46CQ33824419-16DEF634-A36A-4BE8-9166-A56D28FA70FF
P2860
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Seroconversion to antibodies a ...... velopment of Kaposi's sarcoma.
@ast
Seroconversion to antibodies a ...... velopment of Kaposi's sarcoma.
@en
Seroconversion to antibodies a ...... velopment of Kaposi's sarcoma.
@nl
type
label
Seroconversion to antibodies a ...... velopment of Kaposi's sarcoma.
@ast
Seroconversion to antibodies a ...... velopment of Kaposi's sarcoma.
@en
Seroconversion to antibodies a ...... velopment of Kaposi's sarcoma.
@nl
prefLabel
Seroconversion to antibodies a ...... velopment of Kaposi's sarcoma.
@ast
Seroconversion to antibodies a ...... velopment of Kaposi's sarcoma.
@en
Seroconversion to antibodies a ...... velopment of Kaposi's sarcoma.
@nl
P2093
P1476
Seroconversion to antibodies a ...... velopment of Kaposi's sarcoma.
@en
P2093
Kingsley L
Rinaldo CR
P304
P356
10.1056/NEJM199607253350403
P407
P577
1996-07-01T00:00:00Z